Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cerebral Diagnostics is a private Canadian medical device and diagnostics company developing non-invasive brain and sensory diagnostic technologies. Its lead platform, Dynamic Electrical Cortical Imaging, uses conventional EEG inputs and mathematical inverse-solution software to generate real-time three-dimensional visualizations of cortical electrical activity. The company is initially focused on diagnostic applications in sleep disorders and chronic pain, and it has also described sensory-loss and pain-testing tools through its affiliated Tactile Health initiative. Cerebral Diagnostics appears to be an early-stage startup rather than a therapeutics developer, with its value proposition centered on affordable, portable neurodiagnostic and somatosensory assessment systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cerebral Diagnostics.